In December, Walgreen’s announced a 40% stake in Sinopharm Holding Guoda Drugstores in China, expanding the company’s global reach. And the pharma retailer is getting into the data game, having spent over $500 million to-date on updating pharmacy management and data collection system and turning its 88.6 million user “Balance Rewards” program into a customer insight tool. Despite these expansion efforts and stronger than expected Q3 earnings, shareholders have watched the pharma retailer’s shares drop amid Amazon’s plans to buy online pharmacy PillPack.
Looking for leads, investment insights, or competitive intelligence?
News about Walgreens Boots Alliance
The Oracle founder previously stated that Tesla was his second-largest investment.
Tesla’s board now has 11 members, including three women.
Deadlines true last minute shoppers need to know.
The Nasdaq Composite index slumped to the brink of a bear market.